US Amjevita Sales Slide By Almost Two-Thirds

Amgen’s Humira Biosimilar Turnover Slides In US Ahead Of Fresh Wave Of Launches

 
• By David Wallace
  
Amgen logo syringe vials
Amgen saw US sales of its Humira biosimilar drop by nearly two-thirds in Q2 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products